ArticleJTO clinical and research reports2025

J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan.

Eisaku Miyauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.